Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentaxim versus Tetraxim + ActHIB primary vaccination in South Korean infants
2015-005293-38Phase 3
- Sponsor
- Sanofi
- Start
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine, diphtheria toxoid + tetanus toxoid + acellular pertussis, haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b disease (Hib), sponsored by Sanofi.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccinediphtheria toxoid + tetanus toxoid + acellular pertussishaemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2015-005293-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005293-38.